A carregar...
Adverse Events following Cancer Immunotherapy: Obstacles and Opportunities
Oncology has recently undergone a revolutionary change with widespread adoption of immunotherapy for many cancers. Immunotherapy using monoclonal antibodies against “checkpoint” molecules, including PD-1, PD-L1, and CTLA-4, is highly effective in a significant subset of patients. However, immune-rel...
Na minha lista:
| Publicado no: | Trends Immunol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6527345/ https://ncbi.nlm.nih.gov/pubmed/31053497 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.it.2019.04.002 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|